A case report involving a 34-year-old white male who was found dead at home by his roommate is presented. At the time of his death, he was being treated with tramadol/acetaminophen, metaxalone, oxycodone, and amitriptyline. The decedent's mother stated that he had been taking increasing amounts of pain medication in order to sleep at night. There were no significant findings at autopsy; however, toxicology results supported a cause and manner of death resulting from suicidal mixed tramadol and amitriptyline toxicity. This case reports the tissue and fluid distribution of tramadol, amitriptyline, and their metabolites in an acutely fatal ingestion in an effort to document concentrations of these analytes in 12 matrices with respect to one another to assist toxicologists in difficult interpretations.
Introduction
A case of a fatal multidrug overdose involving tramadol and amitriptyline is presented. Although cases have been reported for overdoses involving these two drugs separately or in combination with other drugs, this case is unique in that it (1) is a comprehensive collection and analysis of 12 different fluids and tissues and (2) includes both parent and metabolite concentrations to allow for comparison with trends previously reported in the literature.
Introduced in Germany in the 1970s as a centrally acting analgesic, tramadol (Ultracet, Ortho-McNeil) is a weak opioid with approximately 1/10 the potency of morphine (1) . It was approved for use in the U.S. in 1995 for the treatment of mild to severe pain. Although its mechanism of action is poorly understood, it is thought to inhibit the reuptake of norepinephrine and serotonin. Tramadol undergoes extensive metabolism via N-and O-demethylation followed by conjugation with sulfate and glucuronic acid ( Figure 1 ). N-Desmethyl tramadol (NDT) is pharmacologically inactive, and O-desmethyl tramadol (ODT) is at least twice as active as the parent compound and is presumed to contribute greatly to the toxic effect of the drug. Therapeutic oral dosage ranges between 50 and 150 mg/day, which leads to a therapuetic blood concentration between 0.1 and 0.8 mg/L. It is reported to be toxic between 1.4 and 23 mg/L (2) .
Released by the U.S. Food and Drug Administration for clinical use in 1961 for the treatment of depression, amitriptyline blocks the reuptake of norepinephrine and serotonin, the neurotransmitters thought to be responsible for depression. This tricyclic antidepressant undergoes extensive metabolism to generate its major metabolite, nortriptyline (Figure 2 ), and two hydroxylated metabolites, 10-hydroxy-amitriptyline and 10-hydroxy-nortriptyline. Therapeutic dosage ranges between 50 and 150 mg orally leading to therapeutic blood concentration ranges between 0.01 and 0.16 mg/L daily (2) . Amitriptyline is considered toxic at blood levels > 0.50 mg/L or if combined with metabolite concentration > 1.0 mg/L (1).
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Case History
The decedent was a 34-year-old white male found unresponsive on the floor by his roommate. Because of a motor vehicle accident occurring 6 months prior that left him in chronic pain and depressed, the deceased had current prescriptions for tramadol with acetaminophen, metaxalone, oxycodone, and amitriptyline. Twenty years prior to his death, the decedent attempted suicide by a self-inflicted gunshot wound. He recently informed his mother that he had doubled his medication dosage in an effort to sleep better. There were no significant external or internal injuries noted, and with the ex- / C H 3  7 H  CHC H2CH2N.,,,. CHCH2CH2N,,,.
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>, E~ 9 .00 ception of moderate bilateral pulmonary congestion, the autopsy results were unremarkable.
Experimental
Reagents
Diethyl ether, n-butyl chloride, water, hexane, and n-butyl acetate were all high-performance liquid chromatogrpahy grade. Sulfuric acid and concentrated ammonium hydroxide were purchased from Fisher Scientific (Fair Lawn, NJ). Drug-free blood was obtained from the blood bank at North Carolina Memorial Hospital (Chapel Hill, NC).
Sample preparation
The analytes of interest were extracted from seven tissue homogenates and five other matrices (Table I) by n-butyl chloride/diethyl ether liquid-liquid extraction. All tissue homogenates were prepared as follows: 5 g of tissue was diluted with 15 g of deionized water and homogenized with a Brinkman Polytron | Pt 3000 homogenizer (Westbury, NY). When necessary, tissue aliquots were further diluted to ensure linearity. No sample preparation for blood, urine, and bile specimens was required.
Standards
Stock standards (1 mg/mL)of NDT and ODT (Pharmaceutical Research Institute, Spring House, PA) were prepared by weighing 12.7 and 11.8 rng of the HC1 salts, respectively, and dissolving in 10 mL of methanol. A tramadol stock standard (Cerilliant, Round Rock, TX) was diluted 1:10 with methanol to give a 100 ]Jg/mL solution. Serial dilutions were made to produce the working standard. Amitriptyline and nortriptyline stock standards (Cerilliant) were diluted 1:10 to give a 100 IJg/mL solution and further diluted 1:10 for the resulting 10 lJg/mL working standard mix. A 20 lJg/mL alphaprodine internal standard (ISTD) was prepared by diluting I mL of a 1 mg/mL stock standard of (dl)-alphaprodine (Alltech, State College, PA) to 50 mL with methanol. Quality control standards (qc) were prepared in the same manner as the calibrators by a different analyst.
Extraction procedure
ISTD (50 pL) was added to each sample, standard, and qc. Concentrated ammonium hydroxide (500 IJL) was added to each tube, the solution was vortex mixed, and 7 mL of n-butyl chloride/ethyl ether mixture (75:25) was added. After shaking and centrifuging at 2000 rpm for 10 rain, the organic layer was transferred into a new test tube and back extracted with IM sulfuric acid (2.5 mL). The organic layer was aspirated to waste, and the aqueous layer was washed with 2 mL of hexane. The hexane layer was removed. Concentrated ammonium hydroxide (I mL) was added to the remaining aqueous layer. The tubes were vortex mixed, and the liquid was transferred into a 5-mL conical tube into which I00 pL of n-butyl acetate was added and vortex mixed. The n-butyl acetate extracts were transferred into autosampler vials for instrumental analysis.
Determination of concentration
Tramadol, NDT, ODT, amitriptyline, and nortriptyline concentrations were calculated from a linear regression analysis of the calibrator responses based on the peak-area ratio of analyte to ISTD from a five-point calibration curve, ranging from 0.25 to 4.0 mg/L. All curves met acceptance criteria of an r 2 value of 0.992 or better. The coefficient of variance interrun precision was no greater than 7.5% with an accuracy of 96.1% or better for the 2.0 mg/L control (n = 5) and a coefficient value no greater than 6.5% with an accuracy of 89.2% or better for the 0.25 mg/L control. The intrarun coefficient of variance was no greater than 13.6% with an accuracy of 94.9% or better (n = 5) for all controls.
Gas chromatography with nitrogenphosphorus detection (GC-NPD) analysis
Samples, injected at 2 IJL, were analyzed on a Hewlett-Packard 6890 GC coupled with a Hewlett Packard model G1530A NPD utilizing helium as the carrier gas at a flow rate of 4.9 mL/min. The detector response was recorded and integrated using Agilent ChemStation version A.10.02 software. The oven temperature ramp and column specifications were as follows: 150~ held for 1 min, increased to
NPD temperature settings were 250~ and 320~ respectively. Tissue and blood extract spectra were compared with that of the unextracted analytes. Representative chromatography, relative response, elution order, and retention times are shown in Figures 3 and 4 for a case specimen and calibrator, respectively.
GC-mass spectrometric (MS) analysis
Initial identification of amitriptyline, tramadol, and their metabolites was by GC-MS. A 1-pL aliquot was injected into a Hewlett-Packard model 6890 GC with a splitlsplitless injection port connected to a Hewlett-Packard 5973 mass selective de- tector with an electron ionization source utilizing helium as the carrier gas at a flow rate of 8.4 mL/min. Agilent Chemstation version B.01.00 was used to control the operation of the GC-MS. The GC oven was programmed to an initial temperature of 70~ and a hold time of 2 min, followed by a 15~ ramp to a final temperature of 300~ held for 5.6 min. The total run time was 25.0 min. The injection port and transfer line temperatures were 270~ and 280~ respectively. The narrow bore capillary column was an Agilent DB-5MS capillary column (15 m x 0.25 mm, 0.25-1Jm film thickness). The MS was operated in the full scan mode between rn/z 44 and 550. Tissue and blood extract spectra were compared with that of the unextracted analytes.
Results to see liver concentrations as much as 30 times higher than the blood in postmortem overdose cases (3). Such high ratios have been reported in the literature (Table II) (1-3). TCA blood concentrations, however, can rise by a factor of 2-8 between death and specimen collection and tend to rise at a faster rate in blood obtained from the central cavity as opposed to peripheral blood. This concept is known as postmortem redistribution (PMR) (4) and makes the task of determining whether the cause of death was attributed to an overdose more difficult. A blood concentration of amitriptyline plus nortriptyline > 1 mg/L would typically be considered toxic; however, because of postmortem redistribution, concentrations based solely on blood alone should be interpreted with caution. Because amitriptyline is known to sequester in the liver, this tissue serves as a great resource in the determination of acute overdoses. An amitriptyline/nortriptyline
The drugs of interest obtained from the blood and various tissue specimens are presented in Table I . Routine volatile analysis did not detect the presence of ethanol. Additional laboratory testing resulted in trace amounts of metaxalone and ibuprofen and acetaminophen, oxycodone, and cyclobenzaprine aortic blood concentrations of 140, 0.42, and 0.97 rag/L, respectively. Although these analytes were detected, they were not considered contributory to the death. A resuscitative amount of lidocaine was also detected (Figure 3 ).
Discussion
Tricyclic antidepressants (TCAs) are one of the major causes of death from drug ingestion. Fatalities due to amitriptyline overdose have occurred in adults with doses as low as 600 mg (3) . The data obtained for amitriptyline ingestion seem to follow two common trends observed with all TCAs; liver sequestration and predictable drug/ metabolite ratios that enable interpretation of chronic versus acute ingestion. TCAs are highly lipophilic and possess large volumes of distribution (amitriptyline 6-10 L/kg) (2) suggesting extensive tissue distribution. In the presented case, the amount of drug is 8-58 and 3-34 times higher in the tissue than blood samples for amitriptyline and nortriptyline, respectively (Tables I and II) . Because the liver is a major site of sequestration/deposition, it is not uncommon concentration > 50 mg/kg has been determined to be an indication of acute ingestion (2) . The liver-to-blood ratios reported in this case support this indication (Table II) . Although the drug concentration in the liver is large, it does not exceed that of the lung (Table I ). There are very few reports concerning TCA concentrations in the lung. Tracqui et al. (5) report a lung-to-blood ratio of 18. A study in which rat models were used, demonstrated that postmortem release from the lungs contributed to postmortem drug redistribution (4) . The presented results yield a lung-to-blood ratio of 57 and further suggest that the lung is a major site of sequestration and could have an effect on PMR. All tissue specimens contain larger amounts of the drug and its metabolite than in all other fluids, with the exception of urine. In addition, parentto-desmethyl metabolite ratios of > 2.0 are typical of TCA-related fatalities (5). A similar trend was reported by Baselt (2); however, in a case reported by Tracqui et al. (5) , larger amounts of the metabolite were observed. A smaller parent-tometabolite ratio is observed in cases in which therapeutic amounts of drug were taken and which are not contributory to death. The presented results are consistent with an acute overdose in which the parent drug did not have time to completely metabolize before death occurred (Table III) . Few cases of death involving tramadol alone with associated tissue concentrations have been reported. Several multidrug toxicity cases, however, in which tramadol was detected and may have contributed to death have been published (6) (7) (8) (9) (10) (11) . When comparing the central-to-peripheral blood ratio in three of these cases, tramadol does not appear to show significant postmortem redistribution (Table IV) . In the presented case, however, a central-to-peripheral blood ratio of 5.0 was observed. The elevated central blood concentration and hence central-to-peripheral blood ratio may be elevated because of diffusion from the stomach and/or gastrointestinal tract. We cannot rule out the possibility of perimortem aspiration, which can contaminate airways and induce redistribution into the cardiac blood via the pulmonary vessels. This contamination can be exacerbated with the handling or position of the body. There was no mention of this in the autopsy report because of the lack of gastric sample; the amount of drug in the stomach and gastrointestinal tract are unknown. Given amitriptyline and tramadol have the same pK a of 9.4, diffusion of an oral dose of these drugs may be expected to occur at similar ratios; however, it is unknown when these two drugs were ingested in proximity to one another. It has also been suggested that tramadol does not sequester in liver tissues to a significant degree. Given the not fully understood source of the high central blood concentration, the presented results do not confirm that redistribution from drug-rich tissues and/or liver sequestration is or is not taking place despite historical views on the subject (9) . The largest amount of drug was discovered in the lung. There are also large amounts present in the muscle and spleen. In most reported cases, NDT concentrations in tissues are higher than those of ODT; this was not the case in this report in which there were higher levels of ODT in all tissue samples. Moore et al. (11) reported similar results and suggested that the formation of ODT over NDT with a ratio > I may be a useful indicator of acute death (Table V) . The idea that amitriptyline may be interacting with tramadol, resulting in higher concentrations of ODT cannot be ruled out. Tramadol undergoes metabolism via the Cytochrome P450 2D6. This isoenzyme is also responsible for the metabolism of many compounds such as tricyclic antidepressants, in particular amitriptyline (8) . The presence of amitriptyline, which is a substrate for 2D6, may result in competitive inhibition of the isoenzyme thus disallowing it to fully bind to tramadol resulting in incomplete metabolism and high parent drug concentrations.
